What is the current valuation of the US pharmaceutical robots market?

The market valuation was $889.22 Million in 2024. Read More

What is the projected market size for the US pharmaceutical robots market by 2035?

The market is projected to reach $3099.26 Million by 2035. Read More

What is the expected CAGR for the US pharmaceutical robots market during the forecast period 2025 - 2035?

The expected CAGR is 12.02% during the forecast period. Read More

Which application segments are driving growth in the US pharmaceutical robots market?

Key application segments include Pharmacy Automation, with a valuation of $964.56 Million projected for 2035. Read More

What are the primary end-use segments in the US pharmaceutical robots market?

Pharmaceutical Companies represent a significant end-use segment, projected to reach $1400.0 Million by 2035. Read More

What types of robotic systems are included in the US pharmaceutical robots market?

Robotic Surgery Systems are a major type, expected to grow to $1200.0 Million by 2035. Read More

Which components are essential in the US pharmaceutical robots market?

Hardware is a crucial component, with a projected valuation of $1400.0 Million by 2035. Read More

Who are the key players in the US pharmaceutical robots market?

Key players include Abbott Laboratories, Roche Holding AG, and Omnicell Inc. Read More

How do research institutions contribute to the US pharmaceutical robots market?

Research Institutions are projected to contribute $700.0 Million by 2035. Read More

What is the role of automated dispensing systems in the US pharmaceutical robots market?

Automated Dispensing Systems are expected to reach $800.0 Million by 2035. Read More

US Pharmaceutical Robots Market

ID: MRFR/Pharma/16793-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Pharmaceutical Robots Market Research Report: Size, Share, Trend Analysis By Applications (Laboratory Automation, Pharmacy Automation, Surgical Robotics, Drug Discovery), By End Use (Pharmaceutical Companies, Research Institutions, Hospitals, Contract Manufacturing Organizations), By Types (Automated Dispensing Systems, Robotic Surgery Systems, Robotic Pill Dispensers, Automated Compounding Systems) and By Component (Hardware, Software, Services) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Application (USD Million)
  1. 4.1.1 Laboratory Automation
  2. 4.1.2 Pharmacy Automation
  3. 4.1.3 Surgical Robotics
  4. 4.1.4 Drug Discovery
2. 4.2 Pharmaceutical, BY End Use (USD Million)
  1. 4.2.1 Pharmaceutical Companies
  2. 4.2.2 Research Institutions
  3. 4.2.3 Hospitals
  4. 4.2.4 Contract Manufacturing Organizations
3. 4.3 Pharmaceutical, BY Type (USD Million)
  1. 4.3.1 Automated Dispensing Systems
  2. 4.3.2 Robotic Surgery Systems
  3. 4.3.3 Robotic Pill Dispensers
  4. 4.3.4 Automated Compounding Systems
4. 4.4 Pharmaceutical, BY Component (USD Million)
  1. 4.4.1 Hardware
  2. 4.4.2 Software
  3. 4.4.3 Services
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Holding AG (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens AG (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Omnicell Inc (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Baxter International Inc (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Medtronic PLC (IE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 KUKA AG (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stryker Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Aesynt (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY END USE
4. 6.4 US MARKET ANALYSIS BY TYPE
5. 6.5 US MARKET ANALYSIS BY COMPONENT
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY COMPONENT, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY COMPONENT, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY END USE, 2025-2035 (USD Million)
  3. 7.2.3 BY TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY COMPONENT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US US US Pharmaceutical Robots Market Robots Market Segmentation

US Pharmaceutical Robots Market By Application (USD Million, 2025-2035)

Laboratory Automation
Pharmacy Automation
Surgical Robotics
Drug Discovery

US Pharmaceutical Robots Market By End Use (USD Million, 2025-2035)

US Pharmaceutical Robots Market Companies
Research Institutions
Hospitals
Contract Manufacturing Organizations

US Pharmaceutical Robots Market By Type (USD Million, 2025-2035)

Automated Dispensing Systems
Robotic Surgery Systems
Robotic Pill Dispensers
Automated Compounding Systems

US Pharmaceutical Robots Market By Component (USD Million, 2025-2035)

Hardware
Software
Services

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”